Boston Scientific Corporation has obtained CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease, essential tremor and dystonia says the company.
“We are now using image guided programming tools to optimally define the site of stimulation while we clinically assess the patient,” said Francesca Morgante, professor of Neurology and Eleonor Peel Chair for the study of Ageing at St. George’s University of London. ”This advancement in the technology has substantially cut down our programming time and allowed to improve the symptoms of our patients in a significant shorter time.”
The Vercise Neural Navigator 5 Software, with STIMVIEW XT technology, is the latest addition to the fully integrated portfolio of image guided programming solutions for Boston Scientific DBS Systems. Developed in collaboration with Brainlab, a leading software-driven medical technology company, these tools have demonstrated a reduction in programming time by 56% and provide real-time visualisation and stimulation of each person’s unique brain anatomy.
Read more: FDA approves AGENT DCB for coronary artery disease patients
The software includes an enhanced user interface that displays patient data in a simplified format and gives clinicians access to advanced settings for increased therapy delivery. The software is designed to enable more flexibility to better manage the evolving needs of individual patients at any stage of their condition.
“Our aim is to develop tools that make a meaningful difference to physicians and to people living with neurological conditions alike,” said Vincent Sourdaine, Vice President, Neuromodulation in Europe, Middle East and Africa (EMEA), Boston Scientific. “This software enables more efficiency with DBS therapy to simplify what can otherwise be a time-consuming procedure, freeing up capacity for hospitals and clinicians for more value-added tasks and to provide optimal care for patients.”